{"schema_version":"secwatch.filing_event.v1","accession":"0001490978-26-000059","form_type":"8-K","ticker":"SDGR","cik":"0001490978","company_name":"Schrodinger, Inc.","filed_at":"2026-06-29T20:29:15+00:00","discovered_at":"2026-06-29T20:30:00.526959+00:00","generated_at":"2026-06-29T20:30:16.259337+00:00","sec_items":["7.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Schrödinger receives $57M from Lilly's acquisition of co-founded Ajax Therapeutics","bullets":["Received ~$57M cash from Eli Lilly's acquisition of Ajax Therapeutics, a company co-founded by Schrödinger.","Eligible for additional cash payments upon achievement of specified clinical and regulatory milestones by Ajax.","Acquisition completed June 29, 2026; Ajax is a biotech company co-founded by Schrödinger."],"urls":{"canonical":"https://secwatch.observer/filing/0001490978-26-000059","json":"https://secwatch.observer/filing/0001490978-26-000059.json","markdown":"https://secwatch.observer/filing/0001490978-26-000059.md","text":"https://secwatch.observer/filing/0001490978-26-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1490978/000149097826000059/0001490978-26-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1490978/000149097826000059/sdgr-20260629.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T20:30:16.259337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}